EVEON and CONICIO, a design and engineering agency, have signed a partnership agreement. The two companies aim to strengthen their collaborations, as the consideration of human factors (ergonomics, usability) in the development of innovative medical devices is crucial for their use by patients and healthcare professionals.
Read the latest article published in OnDrugDelivery about the challenges faced by the injectable drug delivery industry. And how EVEON’s solution – the Intuity® Ject MX platform overcomes these challenges, offering a fully automatic autoinjector that enables drug mixing, dosing and injection in the same handheld device.
EVEON is attending in various events this Spring 2023. Save the dates and come to meet us and discuss about your needs and how adaptive optics can improve your projects.
Cell and gene therapy delivery is an emergent and transformative industry.
EVEON and Sensorion collaborating to develop an injection system for the delivery of gene therapy treatments into the inner ear
EVEON exhibited at Pharmapack - booth F68 and at Innovation Gallery, on February 1-2, 2023 in Paris (France).
Read the latest article published in OnDrugDelivery about the current challenges faced by the topical spray-based delivery of therapeutics. And how our Ad-Mist™ spray nozzle overcomes these challenges to harness the potential of this delivery route.
During the last years, drug delivery has evolved and new routes of administration have emerged.
JBT HubUp alliance has celebrated its 5th anniversary and exhibited at the international CPHI exhibition in Frankfurt (Germany), 1-3 November 2022.
EVEON announces the launch of the European project INDENEO to develop an innovative delivery system for nose to brain administration of biological and advanced therapy drugs to neonates.
